Ventaira Pharmaceuticals

company

About

Ventaira Pharmaceuticals is a specialty pharmaceutical company leveraging science and engineering for more effective medicines.

  • 11 - 50

Details

Last Funding Type
Series A
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Apr 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Ventaira Pharmaceuticals has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 19, 2000 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 19, 2000 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ventaira Pharmaceuticals is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Series A